
Rockview Rehabilitation: Alabama-based medical center specializing in Physical Therapy and Lymphedema Management.
Rockview Rehabilitation, based in Muscle Shoals, Alabama, is a medical organization specializing in Physical Therapy and Lymphedema Management. Their core mission is to provide comprehensive care for individuals suffering from lymphedema, a condition often resulting from cancer treatments that cause blockages in the lymphatic system. Rockview Rehabilitation aims to improve patients' quality of life through targeted therapies and personalized treatment plans, focusing on reducing swelling and enhancing mobility.
Notable affiliated individuals and investors remain unspecified, but the organization has made significant strides in the healthcare sector. Key achievements include establishing a specialized center for lymphedema management and gaining recognition for their effective treatment protocols. The overall impact of Rockview Rehabilitation is reflected in the improved health outcomes and enhanced quality of life for their patients, positioning them as a vital healthcare provider in Alabama.

Rehab.com
rehab.com

Rock River Healthcare
rockriverhc.com

Range Rehab
rangerehab.com

Circle Creek Therapy

Shreveport Aquatic AND Land Physical Therapy.

Therasport Physical Therapy
therasport.org

Airrosti
airrosti.com

GeriHab Physical Therapy
gerihabjackson.com

Excel Orthopedic Rehabilitation
exceltherapy.com

Flint Rehab
flintrehab.com

RecoveryOne
recoveryone.com

Rehabilit8

Therapy Plus
therapyplusllc.com

Encompass Health

OnTrack Rehabilitation
Companies similar to Rockview Rehabiliation include Rehab.com, Rock River Healthcare, Range Rehab and Circle Creek Therapy.
Rockview Rehabiliation was founded in 2014.
Rockview Rehabiliation's headquarters is located in Muscle Shoals, AL, US.
Rockview Rehabiliation's most recent funding round was for $100k (USD) in September 2014.
As of Sep 25, 2014, Rockview Rehabiliation has raised a total of $100k (USD).
Rockview Rehabiliation has 5 employees as of Feb 4, 2024.